Growth assessment in Egyptian infants and children with chronic diarrhea

Marwa T Ei-Deeb1, Dalia H Abdel Hamid

  • 1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo 11566, Egypt. dmarwa_eldeeb@yahoo.com

Insights

Chronic diarrhea in Egyptian children is most commonly caused by infections and cow's milk allergy (CMA). Many patients exhibit significant growth impairments, with inflammatory bowel disease (IBD) and CMA linked to the most severe outcomes.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Nutrition

Background:

  • Chronic diarrhea significantly impacts growth and development in infants and children.
  • Identifying the underlying causes is crucial for effective management and improving patient outcomes.

Purpose of the Study:

  • To evaluate growth parameters in Egyptian children with chronic diarrhea.
  • To determine the most prevalent causes of chronic diarrhea in this population.

Main Methods:

  • A cross-sectional study of 146 Egyptian children with chronic diarrhea.
  • Included detailed medical and dietary history, anthropometric measurements (weight, height, z-scores), and extensive laboratory investigations.
  • Diagnostic methods included stool analysis, serology for celiac disease, breath hydrogen tests, endoscopy, and cow's milk allergy (CMA) challenge tests.

Main Results:

  • The most common causes were chronic infections (40.4%), CMA (34.9%), celiac disease (10.3%), and inflammatory bowel disease (IBD) (6.8%).
  • A high prevalence of growth impairment was observed: 78.7% had low weight-for-age (WFA) z-scores, 75% had low length-for-age (HFA) z-scores, and 50.7% showed wasting (low weight-for-height, WFH z-scores).
  • Patients with IBD and CMA showed the most severe growth deficits, indicated by the lowest WFA, HFA, and WFH z-scores.

Conclusions:

  • Chronic diarrhea in Egyptian children is frequently associated with significant malnutrition and growth retardation.
  • Infections and CMA are the leading causes, necessitating targeted diagnostic and therapeutic strategies.
  • Early identification and management of these conditions are vital to mitigate long-term growth consequences.

Related Concept Videos

Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...